Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Current recommendations for the empirical treatment of central nervous system (CNS) infection in the presence of a shunt recommend using IV [[vancomycin]] in combination with an agent that has adequate gram-negative coverage, such as [[cefepime]], [[ceftazidime]], [[cefotaxime]], or [[meropenem]]. The ability of a medication to penetrate the [[CSF]] as well as the activity of the [[antibiotic]] against the bacterial [[biofilm]] are also important to consider for [[antibiotic]] choice ((Yilmaz A, Dalgic N, Musluman M, et al. Linezolid treatment of shunt-related cerebrospinal fluid infections in children. J Neurosurg Pediatr. 2010;5:443-448.)). ceftazidime.txt Last modified: 2024/06/07 02:57by 127.0.0.1